Latest filing published 07 Jan 2026 for GLAUKOS Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Denice Torres across 4 companies, led by GLAUKOS Corp, 2seventy bio, Inc. and bluebird bio, Inc. Between 3 June 2021 and 2 January 2026, the trades on record add up to 18 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 7 January 2026, reports a share grant in GLAUKOS Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations